BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22362224)

  • 1. Highlights from the Pan Pacific Lymphoma Conference. August 15–19, 2011, Kauai, Hawaii.
    Cheson BD
    Clin Adv Hematol Oncol; 2011 Oct; 9(10 Suppl 24):1-24. PubMed ID: 22362224
    [No Abstract]   [Full Text] [Related]  

  • 2. NCCN: Non-Hodgkin's lymphoma.
    Zelenetz AD; Hoppe RT;
    Cancer Control; 2001; 8(6 Suppl 2):102-13. PubMed ID: 11760551
    [No Abstract]   [Full Text] [Related]  

  • 3. Four Lymphomas in 1 Patient: A Unique Case of Triple Composite Non-Hodgkin Lymphoma Followed by Classical Hodgkin Lymphoma.
    Tennese A; Skrabek PJ; Nasr MR; Sekiguchi DR; Morales C; Brown TC; Weisenburger DD; Perry AM
    Int J Surg Pathol; 2017 May; 25(3):276-280. PubMed ID: 27688525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allogeneic transplantation in malignant lymphoma].
    Stötzer OJ; Schleuning M; Ledderose G; Hiddemann W; Kolb HJ
    Dtsch Med Wochenschr; 2001 Sep; 126(39):1062-9. PubMed ID: 11602913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant lymphoma in adults].
    Fridrik MA
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2109-14. PubMed ID: 18985565
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant B-Cell Lymphoma: Advances in the Therapy of Follicular Lymphoma and Mantle-cell Lymphoma].
    Buske C; Dreyling M
    Dtsch Med Wochenschr; 2018 Jan; 143(1):46-51. PubMed ID: 29316585
    [No Abstract]   [Full Text] [Related]  

  • 7. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the treatment of non-Hodgkin's lymphomas.
    Abramson JS; Zelenetz AD
    J Natl Compr Canc Netw; 2013 May; 11(5 Suppl):671-5. PubMed ID: 23704240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of gene expression profiling in molecular classification, prognosis and therapy of B-cell lymphoma].
    Mao ZR; Zhou R; Zhang XX; Mueller-Hermelink Hk; Rosenwald A
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):785-9. PubMed ID: 20079025
    [No Abstract]   [Full Text] [Related]  

  • 10. [Malignant lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma)].
    Kinoshita T
    Rinsho Ketsueki; 2012 Feb; 53(2):145-54. PubMed ID: 22450573
    [No Abstract]   [Full Text] [Related]  

  • 11. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
    Foran JM; Rohatiner AZ; Cunningham D; Popescu RA; Solal-Celigny P; Ghielmini M; Coiffier B; Johnson PW; Gisselbrecht C; Reyes F; Radford JA; Bessell EM; Souleau B; Benzohra A; Lister TA
    J Clin Oncol; 2000 Jan; 18(2):317-24. PubMed ID: 10637245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allogeneic haematopoietic cell transplantation for indolent lymphomas: Guidelines from the Francophone Society Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
    Bull Cancer; 2017 Dec; 104(12S):S121-S130. PubMed ID: 29173973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic cell transplantation in non-Hodgkin's lymphoma.
    Steingass SK
    Semin Oncol Nurs; 2006 May; 22(2):107-16. PubMed ID: 16720233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
    Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of lymphoma.
    Abbott BL
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):30-2. PubMed ID: 16879767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal residual disease: lessons to be learned from malignant lymphoma.
    Armitage JO
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():73-5. PubMed ID: 2202473
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant lymphoma of the lacrimal gland: a nation-based study.
    Rasmussen P; Ralfkiaer E; Prause JU; Sjö LD; Siersma VD; Heegaard S
    Arch Ophthalmol; 2011 Oct; 129(10):1275-80. PubMed ID: 21987669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphomas.
    Longo DL; Devita VT
    Cancer Chemother Biol Response Modif; 1988; 10():148-81. PubMed ID: 3079382
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes.
    Corradini P; Ladetto M; Zallio F; Astolfi M; Rizzo E; Sametti S; Cuttica A; Rosato R; Farina L; Boccadoro M; Benedetti F; Pileri A; Tarella C
    J Clin Oncol; 2004 Apr; 22(8):1460-8. PubMed ID: 15084619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highlights in Lymphoma From the 2015 ASH Meeting: Commentary.
    Chen RW
    Clin Adv Hematol Oncol; 2016 Feb; 14(2 Suppl 1):18-23. PubMed ID: 27007009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.